IRIS

Methanol

CASRN 67-56-1 | DTXSID2021731

IRIS Toxicological Review of Methanol (Interagency Science Consultation Draft)

On this page:

Notice - This site contains archived material(s)

Archive disclaimer
Archived files are provided for reference purposes only. The file was current when produced, but is no longer maintained and may now be outdated. Persons with disabilities having difficulty accessing archived files may contact the Risk Webmaster for assistance. Please use the contact us form if you need additional support.


Overview

On January 12, 2010, the Toxicological Review of Methanol and the charge to external peer reviewers were released for external peer review and public comment. The Toxicological Review and charge were reviewed internally by EPA and by other federal agencies and White House Offices before public release. In the new IRIS process, introduced by the EPA Administrator, all written comments on IRIS assessments submitted by other federal agencies and White House Offices will be made publicly available. Accordingly, interagency comments and the interagency science consultation draft of the IRIS Toxicological Review of Methanol and the charge to external peer reviewers are posted on this site.

Citation

U.S. EPA. IRIS Toxicological Review of Methanol (Interagency Science Consultation Draft). U.S. Environmental Protection Agency, Washington, DC, 2009.

Top of Page


Background

Methanol is a high production volume chemical with many commercial uses. It is a basic building block for numerous chemicals. Many of its derivatives are used in the construction, housing or automotive industries. Consumer products that contain methanol include varnishes, shellacs, paints, windshield washer fluid, antifreeze, adhesives, deicers, and Sterno heaters. This draft IRIS health assessment addresses both non-cancer and cancer human health effects that may result from chronic exposure to this chemical. This draft assessment provides an inhalation reference concentration (RfC) for chronic non-cancer health effects, a cancer assessment, and a reassessment of the oral reference dose (RfD). This is the first RfC and cancer assessment for methanol.

History/Chronology

Date Description
01- Sep 1988 EPA posted the assessment of an oral reference dose for methanol on the IRIS Database.
02- Jul 1993 EPA revised the oral reference dose for methanol.
03- May 2002 EPA started draft development of an IRIS reassessment of methanol.
04- Jun 2009 An external peer review of unpublished New Energy Development Organization (NEDO) studies (for a 24-month rat study and an 18-month mouse study) was completed.
05- Dec 2009 EPA hosted an interagency science consultation on the draft IRIS Toxicological Review of Methanol for cancer and non-cancer health effects.
06- Jan 2010 EPA released the IRIS Toxicological Review of Methanol (External Review Draft) on cancer and non-cancer health effects for public review and comment, and announced the public listening session would be held on February 23, 2010. [Federal Register Jan 12, 2010]
07- Jun 2010 Following a report from the National Toxicology Program, EPA placed on hold the draft Methanol Toxicological Review on cancer and non-cancer health effects. [See June 15, 2010 SAB press release]
08- Apr 2011 EPA released the IRIS Toxicological Review of Methanol (Non-Cancer) (External Review Draft) for public review and comment. EPA also announced a public listening session to be held on May 26, 2011 in Arlington, VA. [Federal Register Apr 18, 2011]

Status

Following external peer review the assessment will be revised taking into consideration external peer review and public comments, will undergo a final EPA internal review and a review by a science discussion with other federal agencies and White House offices, then will be posted to the IRIS Web site.

Top of Page

Download(s)

This download(s) is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally disseminated by EPA. It does not represent and should not be construed to represent any Agency determination or policy.

If you have a disability and the format of any material on our web pages interferes with your ability to access the information, please reach out to us using the Contact Us about IRIS form for assistance. To enable us to respond in a manner most helpful to you, please indicate the nature of the accessibility problem, the web address of the requested material, your preferred format in which you want to receive the material (electronic format (ASCII, etc.), standard print, large print, etc.), and your contact information.

Top of Page